NCT03701035View on ClinicalTrials.gov

Moderate Intensity Aerobic Training in Sub-acute and Chronic Stroke Patients - the Influence on Brain Derived Neurotrophic Factor (BDNF) and Upper-limb Rehabilitation. A Protocol for a Randomized Control Trial and Health Economic Evaluation

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

September 1, 2020

Study Completion Date

September 1, 2020

Conditions
Stroke
Interventions
BEHAVIORAL

Aerobic Training & UL Motor Training

Aerobic training at 40%-59% Heart Rate Reserve (AT) increasing from personal maximum time (if \< 40 mins) to 40 minutes followed by UL motor training with the Armeo®Spring/Senso/Pablo X2®

BEHAVIORAL

Non-aerobic training & UL Motor Training

40 minutes non-aerobic gait \& balance circuit training followed by UL motor training with the Armeo®Spring/Senso/Pablo X2®

Trial Locations (1)

4055

RehaB clinic for Neurorehabilitation and Paraplegiology, Basel

All Listed Sponsors
collaborator

Bildungszetrum Gesundheit Basel-Stadt

UNKNOWN

collaborator

Rehab Basel

OTHER

lead

Clare Maguire

OTHER

NCT03701035 - Moderate Intensity Aerobic Training in Sub-acute and Chronic Stroke Patients - the Influence on Brain Derived Neurotrophic Factor (BDNF) and Upper-limb Rehabilitation. A Protocol for a Randomized Control Trial and Health Economic Evaluation | Biotech Hunter | Biotech Hunter